Patients dealing with hypotension, or dangerously low blood pressure, can now be treated with a drug initially developed by George Washington University researcher Lakhmir Chawla from the School of Medicine and Health Sciences and the GW Medical Faculty Associates.
{iframe}https://gwtoday.gwu.edu/commercialization-brings-research-%E2%80%98broad-benefits%E2%80%99-market{/iframe}